EFFECTS OF LANDIOLOL ON MECHANICAL AND METABOLIC CHANGES IN RAT REPERFUSED ISCHAEMIC HEARTS

SUMMARY 1 The aim of the present study was to clarify the effects of landiolol, a short‐acting selective β1‐adrenoceptor blocking agent, on mechanical and metabolic changes in postischaemic perfused hearts. 2 Rat isolated hearts (n = 30) were randomly separated into non‐ischaemic or ischaemic groups...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental pharmacology & physiology 2007-01, Vol.34 (1‐2), p.55-60
Hauptverfasser: Sakanashi, Makiko, Sakanashi, Mayuko, Sugahara, Kazuhiro, Sakanashi, Matao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 60
container_issue 1‐2
container_start_page 55
container_title Clinical and experimental pharmacology & physiology
container_volume 34
creator Sakanashi, Makiko
Sakanashi, Mayuko
Sugahara, Kazuhiro
Sakanashi, Matao
description SUMMARY 1 The aim of the present study was to clarify the effects of landiolol, a short‐acting selective β1‐adrenoceptor blocking agent, on mechanical and metabolic changes in postischaemic perfused hearts. 2 Rat isolated hearts (n = 30) were randomly separated into non‐ischaemic or ischaemic groups. The latter group was further divided into Krebs’–Henseleit solution (KHS)‐ and landiolol (30, 100 or 300 µmol/L)‐treated groups. Ischaemic hearts were subjected to 25 min global ischaemia and 20 min reperfusion under atrial pacing. Time‐course changes in left ventricular (LV) end‐diastolic pressure (LVEDP), LV developed pressure (LVDP), peak positive velocity of change of LV pressure (LVdP/dtmax) and coronary flow were observed along with tissue contents of adenosine triphosphate (ATP), creatine phosphate, inorganic phosphate (Pi), malondialdehyde (MDA) and lactate dehydrogenase (LDH) release in coronary effluent. The effects of landiolol on rat isolated aortic preparations under KCl contraction were also investigated. 3 Ischaemia–reperfusion significantly impaired cardiodynamics, such as LVEDP, LVDP and LVdP/dtmax, decreased myocardial ATP content and increased Pi and LDH release. In the 30 µmol/L landiolol‐treated group, cardiovascular parameters impaired by ischaemia–reperfusion and increased LDH release were further exacerbated and myocardial MDA content was significantly increased. In the 300 µmol/L landiolol‐treated group, cardiac contractile dysfunction was improved and myocardial MDA, ATP and Pi contents were preserved. All measurements in the 100 µmol/L landiolol‐treated group were similar to those in the ischaemic KHS group. Furthermore, significant relaxations of isolated aortic preparations were obtained with landiolol 30–1000 µmol/L, suggesting a possible calcium antagonism with landiolol. 4 In conclusion, landiolol, at low concentrations, aggravated myocardial ischaemia–reperfusion injuries, whereas at high concentrations it ameliorated them. The former effect may be mediated by the production of reactive oxygen species, whereas the latter may involve calcium antagonist activity.
doi_str_mv 10.1111/j.1440-1681.2007.04543.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68394232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68394232</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2943-18971da4e4a7df88ed1d26e5c1ee4b3efc5200ec68712d1b9e556ae61b82683</originalsourceid><addsrcrecordid>eNqFkU9PgzAYhxujcXP6FUxP3sC-tBQ4eEBWNhIGC-DJQ8OfLtnC3Bwubt_e4qYe7aXt-3vy5m0fhDAQE_R6XJnAGDGAu2BahDgmYTaj5uECDX-DSzQklNgGuA4ZoJuuWxFCbMLpNRqAYxFwKB-iVxGGIihynIY49pNxlMZpjNMEz0Qw9ZMo8GOsy_pa-M9pHAW4L09EjqMEZ36BMzEXWfiSizGOcp2JmWamws-K_BZdLcq2U3fnfYTyUBTB1IjTSd_Y2Foeo3pAz4GmZIqVTrNwXdVAY3Fl16AUq6ha1LZ-o6q564DVQOUp2-al4lC5FnfpCD2cum53m_e96j7ketnVqm3LN7XZd1IjHrOo9S8Ins2BuqDB-zO4r9aqkdvdcl3ujvLn1zTwdAI-l606_uVE9nbkSvYSZC9B9nbktx15kIGY9yf6BQQ1eTc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19561381</pqid></control><display><type>article</type><title>EFFECTS OF LANDIOLOL ON MECHANICAL AND METABOLIC CHANGES IN RAT REPERFUSED ISCHAEMIC HEARTS</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Sakanashi, Makiko ; Sakanashi, Mayuko ; Sugahara, Kazuhiro ; Sakanashi, Matao</creator><creatorcontrib>Sakanashi, Makiko ; Sakanashi, Mayuko ; Sugahara, Kazuhiro ; Sakanashi, Matao</creatorcontrib><description>SUMMARY 1 The aim of the present study was to clarify the effects of landiolol, a short‐acting selective β1‐adrenoceptor blocking agent, on mechanical and metabolic changes in postischaemic perfused hearts. 2 Rat isolated hearts (n = 30) were randomly separated into non‐ischaemic or ischaemic groups. The latter group was further divided into Krebs’–Henseleit solution (KHS)‐ and landiolol (30, 100 or 300 µmol/L)‐treated groups. Ischaemic hearts were subjected to 25 min global ischaemia and 20 min reperfusion under atrial pacing. Time‐course changes in left ventricular (LV) end‐diastolic pressure (LVEDP), LV developed pressure (LVDP), peak positive velocity of change of LV pressure (LVdP/dtmax) and coronary flow were observed along with tissue contents of adenosine triphosphate (ATP), creatine phosphate, inorganic phosphate (Pi), malondialdehyde (MDA) and lactate dehydrogenase (LDH) release in coronary effluent. The effects of landiolol on rat isolated aortic preparations under KCl contraction were also investigated. 3 Ischaemia–reperfusion significantly impaired cardiodynamics, such as LVEDP, LVDP and LVdP/dtmax, decreased myocardial ATP content and increased Pi and LDH release. In the 30 µmol/L landiolol‐treated group, cardiovascular parameters impaired by ischaemia–reperfusion and increased LDH release were further exacerbated and myocardial MDA content was significantly increased. In the 300 µmol/L landiolol‐treated group, cardiac contractile dysfunction was improved and myocardial MDA, ATP and Pi contents were preserved. All measurements in the 100 µmol/L landiolol‐treated group were similar to those in the ischaemic KHS group. Furthermore, significant relaxations of isolated aortic preparations were obtained with landiolol 30–1000 µmol/L, suggesting a possible calcium antagonism with landiolol. 4 In conclusion, landiolol, at low concentrations, aggravated myocardial ischaemia–reperfusion injuries, whereas at high concentrations it ameliorated them. The former effect may be mediated by the production of reactive oxygen species, whereas the latter may involve calcium antagonist activity.</description><identifier>ISSN: 0305-1870</identifier><identifier>EISSN: 1440-1681</identifier><identifier>DOI: 10.1111/j.1440-1681.2007.04543.x</identifier><identifier>PMID: 17201736</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Adenosine Triphosphate - metabolism ; Adrenergic beta-Antagonists - pharmacology ; Animals ; Aorta - drug effects ; Aorta - physiopathology ; calcium antagonism ; cardiodynamics ; In Vitro Techniques ; ischaemia–reperfusion ; L-Lactate Dehydrogenase - metabolism ; landiolol ; Lipid Peroxidation - drug effects ; Male ; Malondialdehyde - metabolism ; Morpholines - pharmacology ; Myocardial Ischemia - metabolism ; Myocardial Ischemia - physiopathology ; Myocardial Reperfusion Injury - drug therapy ; Myocardial Reperfusion Injury - metabolism ; Myocardial Reperfusion Injury - physiopathology ; Myocardium - metabolism ; Phosphates - metabolism ; Phosphocreatine - metabolism ; Rats ; Rats, Wistar ; reactive oxygen species ; Urea - analogs &amp; derivatives ; Urea - pharmacology ; Vasodilation - drug effects ; Vasodilator Agents - pharmacology</subject><ispartof>Clinical and experimental pharmacology &amp; physiology, 2007-01, Vol.34 (1‐2), p.55-60</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1440-1681.2007.04543.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1440-1681.2007.04543.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17201736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakanashi, Makiko</creatorcontrib><creatorcontrib>Sakanashi, Mayuko</creatorcontrib><creatorcontrib>Sugahara, Kazuhiro</creatorcontrib><creatorcontrib>Sakanashi, Matao</creatorcontrib><title>EFFECTS OF LANDIOLOL ON MECHANICAL AND METABOLIC CHANGES IN RAT REPERFUSED ISCHAEMIC HEARTS</title><title>Clinical and experimental pharmacology &amp; physiology</title><addtitle>Clin Exp Pharmacol Physiol</addtitle><description>SUMMARY 1 The aim of the present study was to clarify the effects of landiolol, a short‐acting selective β1‐adrenoceptor blocking agent, on mechanical and metabolic changes in postischaemic perfused hearts. 2 Rat isolated hearts (n = 30) were randomly separated into non‐ischaemic or ischaemic groups. The latter group was further divided into Krebs’–Henseleit solution (KHS)‐ and landiolol (30, 100 or 300 µmol/L)‐treated groups. Ischaemic hearts were subjected to 25 min global ischaemia and 20 min reperfusion under atrial pacing. Time‐course changes in left ventricular (LV) end‐diastolic pressure (LVEDP), LV developed pressure (LVDP), peak positive velocity of change of LV pressure (LVdP/dtmax) and coronary flow were observed along with tissue contents of adenosine triphosphate (ATP), creatine phosphate, inorganic phosphate (Pi), malondialdehyde (MDA) and lactate dehydrogenase (LDH) release in coronary effluent. The effects of landiolol on rat isolated aortic preparations under KCl contraction were also investigated. 3 Ischaemia–reperfusion significantly impaired cardiodynamics, such as LVEDP, LVDP and LVdP/dtmax, decreased myocardial ATP content and increased Pi and LDH release. In the 30 µmol/L landiolol‐treated group, cardiovascular parameters impaired by ischaemia–reperfusion and increased LDH release were further exacerbated and myocardial MDA content was significantly increased. In the 300 µmol/L landiolol‐treated group, cardiac contractile dysfunction was improved and myocardial MDA, ATP and Pi contents were preserved. All measurements in the 100 µmol/L landiolol‐treated group were similar to those in the ischaemic KHS group. Furthermore, significant relaxations of isolated aortic preparations were obtained with landiolol 30–1000 µmol/L, suggesting a possible calcium antagonism with landiolol. 4 In conclusion, landiolol, at low concentrations, aggravated myocardial ischaemia–reperfusion injuries, whereas at high concentrations it ameliorated them. The former effect may be mediated by the production of reactive oxygen species, whereas the latter may involve calcium antagonist activity.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Adrenergic beta-Antagonists - pharmacology</subject><subject>Animals</subject><subject>Aorta - drug effects</subject><subject>Aorta - physiopathology</subject><subject>calcium antagonism</subject><subject>cardiodynamics</subject><subject>In Vitro Techniques</subject><subject>ischaemia–reperfusion</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>landiolol</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Male</subject><subject>Malondialdehyde - metabolism</subject><subject>Morpholines - pharmacology</subject><subject>Myocardial Ischemia - metabolism</subject><subject>Myocardial Ischemia - physiopathology</subject><subject>Myocardial Reperfusion Injury - drug therapy</subject><subject>Myocardial Reperfusion Injury - metabolism</subject><subject>Myocardial Reperfusion Injury - physiopathology</subject><subject>Myocardium - metabolism</subject><subject>Phosphates - metabolism</subject><subject>Phosphocreatine - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>reactive oxygen species</subject><subject>Urea - analogs &amp; derivatives</subject><subject>Urea - pharmacology</subject><subject>Vasodilation - drug effects</subject><subject>Vasodilator Agents - pharmacology</subject><issn>0305-1870</issn><issn>1440-1681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9PgzAYhxujcXP6FUxP3sC-tBQ4eEBWNhIGC-DJQ8OfLtnC3Bwubt_e4qYe7aXt-3vy5m0fhDAQE_R6XJnAGDGAu2BahDgmYTaj5uECDX-DSzQklNgGuA4ZoJuuWxFCbMLpNRqAYxFwKB-iVxGGIihynIY49pNxlMZpjNMEz0Qw9ZMo8GOsy_pa-M9pHAW4L09EjqMEZ36BMzEXWfiSizGOcp2JmWamws-K_BZdLcq2U3fnfYTyUBTB1IjTSd_Y2Foeo3pAz4GmZIqVTrNwXdVAY3Fl16AUq6ha1LZ-o6q564DVQOUp2-al4lC5FnfpCD2cum53m_e96j7ketnVqm3LN7XZd1IjHrOo9S8Ins2BuqDB-zO4r9aqkdvdcl3ujvLn1zTwdAI-l606_uVE9nbkSvYSZC9B9nbktx15kIGY9yf6BQQ1eTc</recordid><startdate>200701</startdate><enddate>200701</enddate><creator>Sakanashi, Makiko</creator><creator>Sakanashi, Mayuko</creator><creator>Sugahara, Kazuhiro</creator><creator>Sakanashi, Matao</creator><general>Blackwell Publishing Asia</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QP</scope><scope>7X8</scope></search><sort><creationdate>200701</creationdate><title>EFFECTS OF LANDIOLOL ON MECHANICAL AND METABOLIC CHANGES IN RAT REPERFUSED ISCHAEMIC HEARTS</title><author>Sakanashi, Makiko ; Sakanashi, Mayuko ; Sugahara, Kazuhiro ; Sakanashi, Matao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2943-18971da4e4a7df88ed1d26e5c1ee4b3efc5200ec68712d1b9e556ae61b82683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Adrenergic beta-Antagonists - pharmacology</topic><topic>Animals</topic><topic>Aorta - drug effects</topic><topic>Aorta - physiopathology</topic><topic>calcium antagonism</topic><topic>cardiodynamics</topic><topic>In Vitro Techniques</topic><topic>ischaemia–reperfusion</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>landiolol</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Male</topic><topic>Malondialdehyde - metabolism</topic><topic>Morpholines - pharmacology</topic><topic>Myocardial Ischemia - metabolism</topic><topic>Myocardial Ischemia - physiopathology</topic><topic>Myocardial Reperfusion Injury - drug therapy</topic><topic>Myocardial Reperfusion Injury - metabolism</topic><topic>Myocardial Reperfusion Injury - physiopathology</topic><topic>Myocardium - metabolism</topic><topic>Phosphates - metabolism</topic><topic>Phosphocreatine - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>reactive oxygen species</topic><topic>Urea - analogs &amp; derivatives</topic><topic>Urea - pharmacology</topic><topic>Vasodilation - drug effects</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakanashi, Makiko</creatorcontrib><creatorcontrib>Sakanashi, Mayuko</creatorcontrib><creatorcontrib>Sugahara, Kazuhiro</creatorcontrib><creatorcontrib>Sakanashi, Matao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental pharmacology &amp; physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakanashi, Makiko</au><au>Sakanashi, Mayuko</au><au>Sugahara, Kazuhiro</au><au>Sakanashi, Matao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EFFECTS OF LANDIOLOL ON MECHANICAL AND METABOLIC CHANGES IN RAT REPERFUSED ISCHAEMIC HEARTS</atitle><jtitle>Clinical and experimental pharmacology &amp; physiology</jtitle><addtitle>Clin Exp Pharmacol Physiol</addtitle><date>2007-01</date><risdate>2007</risdate><volume>34</volume><issue>1‐2</issue><spage>55</spage><epage>60</epage><pages>55-60</pages><issn>0305-1870</issn><eissn>1440-1681</eissn><abstract>SUMMARY 1 The aim of the present study was to clarify the effects of landiolol, a short‐acting selective β1‐adrenoceptor blocking agent, on mechanical and metabolic changes in postischaemic perfused hearts. 2 Rat isolated hearts (n = 30) were randomly separated into non‐ischaemic or ischaemic groups. The latter group was further divided into Krebs’–Henseleit solution (KHS)‐ and landiolol (30, 100 or 300 µmol/L)‐treated groups. Ischaemic hearts were subjected to 25 min global ischaemia and 20 min reperfusion under atrial pacing. Time‐course changes in left ventricular (LV) end‐diastolic pressure (LVEDP), LV developed pressure (LVDP), peak positive velocity of change of LV pressure (LVdP/dtmax) and coronary flow were observed along with tissue contents of adenosine triphosphate (ATP), creatine phosphate, inorganic phosphate (Pi), malondialdehyde (MDA) and lactate dehydrogenase (LDH) release in coronary effluent. The effects of landiolol on rat isolated aortic preparations under KCl contraction were also investigated. 3 Ischaemia–reperfusion significantly impaired cardiodynamics, such as LVEDP, LVDP and LVdP/dtmax, decreased myocardial ATP content and increased Pi and LDH release. In the 30 µmol/L landiolol‐treated group, cardiovascular parameters impaired by ischaemia–reperfusion and increased LDH release were further exacerbated and myocardial MDA content was significantly increased. In the 300 µmol/L landiolol‐treated group, cardiac contractile dysfunction was improved and myocardial MDA, ATP and Pi contents were preserved. All measurements in the 100 µmol/L landiolol‐treated group were similar to those in the ischaemic KHS group. Furthermore, significant relaxations of isolated aortic preparations were obtained with landiolol 30–1000 µmol/L, suggesting a possible calcium antagonism with landiolol. 4 In conclusion, landiolol, at low concentrations, aggravated myocardial ischaemia–reperfusion injuries, whereas at high concentrations it ameliorated them. The former effect may be mediated by the production of reactive oxygen species, whereas the latter may involve calcium antagonist activity.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>17201736</pmid><doi>10.1111/j.1440-1681.2007.04543.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-1870
ispartof Clinical and experimental pharmacology & physiology, 2007-01, Vol.34 (1‐2), p.55-60
issn 0305-1870
1440-1681
language eng
recordid cdi_proquest_miscellaneous_68394232
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adenosine Triphosphate - metabolism
Adrenergic beta-Antagonists - pharmacology
Animals
Aorta - drug effects
Aorta - physiopathology
calcium antagonism
cardiodynamics
In Vitro Techniques
ischaemia–reperfusion
L-Lactate Dehydrogenase - metabolism
landiolol
Lipid Peroxidation - drug effects
Male
Malondialdehyde - metabolism
Morpholines - pharmacology
Myocardial Ischemia - metabolism
Myocardial Ischemia - physiopathology
Myocardial Reperfusion Injury - drug therapy
Myocardial Reperfusion Injury - metabolism
Myocardial Reperfusion Injury - physiopathology
Myocardium - metabolism
Phosphates - metabolism
Phosphocreatine - metabolism
Rats
Rats, Wistar
reactive oxygen species
Urea - analogs & derivatives
Urea - pharmacology
Vasodilation - drug effects
Vasodilator Agents - pharmacology
title EFFECTS OF LANDIOLOL ON MECHANICAL AND METABOLIC CHANGES IN RAT REPERFUSED ISCHAEMIC HEARTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T07%3A22%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EFFECTS%20OF%20LANDIOLOL%20ON%20MECHANICAL%20AND%20METABOLIC%20CHANGES%20IN%20RAT%20REPERFUSED%20ISCHAEMIC%20HEARTS&rft.jtitle=Clinical%20and%20experimental%20pharmacology%20&%20physiology&rft.au=Sakanashi,%20Makiko&rft.date=2007-01&rft.volume=34&rft.issue=1%E2%80%902&rft.spage=55&rft.epage=60&rft.pages=55-60&rft.issn=0305-1870&rft.eissn=1440-1681&rft_id=info:doi/10.1111/j.1440-1681.2007.04543.x&rft_dat=%3Cproquest_pubme%3E68394232%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19561381&rft_id=info:pmid/17201736&rfr_iscdi=true